WP
RLAY icon

Woodline Partners’s Relay Therapeutics RLAY Stock Holding History

Woodline Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4M Buy
929,692
+250,350
+37% +$3.63M 0.05% 401
2026
Q1 		$6.76M Buy
679,342
+227
+0% +$2.03K 0.03% 602
2025
Q4 		$5.75M Sell
679,115
-339,000
-33% -$2.42M 0.02% 596
2025
Q3 		$5.31M Hold
1,018,115
– – 0.03% 552
2025
Q2 		$3.52M Sell
1,018,115
-500,446
-33% -$1.49M 0.02% 621
2025
Q1 		$3.98M Buy
1,518,561
+1,241,657
+448% +$4.87M 0.03% 560
2024
Q4 		$1.14M Hold
276,904
– – 0.01% 737
2024
Q3 		$1.96M Buy
276,904
+3,288
+1% +$24.6K 0.02% 479
2024
Q2 		$1.78M Buy
273,616
+608
+0.2% +$4.15K 0.02% 429
2024
Q1 		$2.27M Buy
273,008
+23,008
+9% +$224K 0.02% 421
2023
Q4 		$2.75M Hold
250,000
– – 0.03% 363
2023
Q3 		$2.1M Hold
250,000
– – 0.02% 395
2023
Q2 		$3.14M Sell
250,000
-25,000
-9% -$311K 0.04% 367
2023
Q1 		$4.53M Sell
275,000
-56,663
-17% -$1.02M 0.06% 309
2022
Q4 		$4.96M Hold
331,663
– – 0.07% 319
2022
Q3 		$7.42M Hold
331,663
– – 0.1% 236
2022
Q2 		$5.55M Hold
331,663
– – 0.09% 245
2022
Q1 		$9.93M Buy
331,663
+76,062
+30% +$1.85M 0.16% 177
2021
Q4 		$7.85M Hold
255,601
– – 0.11% 227
2021
Q3 		$8.06M Sell
255,601
-32,956
-11% -$1.11M 0.13% 185
2021
Q2 		$10.6M Buy
288,557
+50,117
+21% +$1.65M 0.2% 131
2021
Q1 		$8.24M Sell
238,440
-54,775
-19% -$2.38M 0.18% 142
2020
Q4 		$12.2M Sell
293,215
-58,608
-17% -$2.65M 0.32% 94
2020
Q3 		$15M Buy
+351,823
New +$13.4M 0.49% 58

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Woodline Partners's RLAY Position: Q2 2026 in Review

Woodline Partners increased its Relay Therapeutics (RLAY) stake by 37% in Q2 2026, buying an estimated $3.63M and bringing the position to 929,692 shares worth $17.4M. The position accounts for 0.05% of the portfolio, ranked #401.

Woodline Partners first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Woodline Partners held 929,692 shares of Relay Therapeutics worth $17.4M as of Q2 2026.
  • Woodline Partners bought 250,350 Relay Therapeutics shares in Q2 2026, an estimated $3.63M.
  • Relay Therapeutics made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #401 holding.
  • Woodline Partners first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.